(12) United States Patent (10) Patent No.: US 8,557,285 B2 Plachetka (45) Date of Patent: *Oct

(12) United States Patent (10) Patent No.: US 8,557,285 B2 Plachetka (45) Date of Patent: *Oct

US008557285B2 (12) United States Patent (10) Patent No.: US 8,557,285 B2 Plachetka (45) Date of Patent: *Oct. 15, 2013 (54) PHARMACEUTICAL COMPOSITIONS FOR (56) References Cited THE COORONATED DELVERY OF NSAIDS U.S. PATENT DOCUMENTS (75) Inventor: John R. Plachetka, Chapel Hill, NC 4,198.390 A 4, 1980 Rider ............................ 424/471 (US) 4.255.431 A 3/1981 Junggren et al. .............. 514,338 (73) Assignee: Pozen Inc., Chapel Hill, NC (US) (Continued) (*) Notice: Subject to any disclaimer, the term of this FOREIGN PATENT DOCUMENTS patent is extended or adjusted under 35 AU 2006235929 11, 2006 U.S.C. 154(b) by 0 days. CA 2139653 T 2001 This patent is Subject to a terminal dis (Continued) claimer. OTHER PUBLICATIONS (21) Appl. No.: 13/215,855 Goldstein et al., “PN400 significantly improves upper (22) Filed: Aug. 23, 2011 gastrointestinal tolerability compared with enteric-coated naproxen alone in patients requiring chronic NSAID therapy: Results from (65) Prior Publication Data Two Prospective, Randomized, Controlled Trials.” POZEN Inc. sponsored study, 2009. (Document D15 from Letter to European US 2012/OO64156A1 Mar. 15, 2012 Patent Office for counterpart European Application No. 02734602.2, Related U.S. Application Data regarding Oral Proceedings dated Dec. 18, 2009). (60) Division of application No. 12/553,804, filed on Sep. (Continued) 3, 2009, now abandoned, which is a division of application No. 11/129,320, filed on May 16, 2005, Primary Examiner — Nissa Westerberg now Pat. No. 8,206,741, which is a (74) Attorney, Agent, or Firm — Parker Highlander PLLC continuation-in-part of application No. 10/158,216, filed on May 31, 2002, now Pat. No. 6,926,907. (57) ABSTRACT (60) Provisional application No. 60/294,588, filed on Jun. The present invention is directed to drug dosage forms that 1, 2001. release an agent that raises the pH of a patient's gastrointes (51) Int. C. tinal tract, followed by a non-steroidal anti-inflammatory A6 IK 9/22 (2006.01) drug. The dosage form is designed so that the NSAID is not A6 IK9/32 (2006.01) released until the intragastric pH has been raised to a safe A61 K9/24 (2006.01) level. The invention also encompasses methods of treating A61 K9/52 (2006.01) patients by administering this coordinated release, gastropro U.S. C. tective, antiarthritic/analgesic combination unit dosage form (52) to achieve pain and symptom relief with a reduced risk of USPC ........... 424/472: 424/457; 424/463; 424/468; developing gastrointestinal damage such as ulcers, erosions 424/474; 424/482 and hemorrhages. (58) Field of Classification Search None See application file for complete search history. 4 Claims, 2 Drawing Sheets BARRERF COAT NAPROXENSODIUM CORE TABLET ENERC FM COAT ACED INHIBITOR COAT US 8,557,285 B2 Page 2 (56) References Cited 6,632,451 B2 10/2003 Penhasi et al. ................ 424/464 6,641,838 B2 11/2003 Pather et al. ... 424/466 U.S. PATENT DOCUMENTS 6,645,988 B2 11/2003 Phillips ........ ... 514,338 6,673,819 B2 1/2004 Bergman et al. .............. 514,338 4,344,929 A 8, 1982 Bonsen et al. ................ 424/466 6,685,964 B1 2/2004 Bartholomaeus et al. ... 424/489 4,508,905 A 4, 1985 Junggren et al. 546,273.7 6,699,885 B2 3/2004 Phillips .................. ... 514,338 4.554.276 A 1 1/1985 LaMattina .................... 514,272 6,713,089 B1 3/2004 Bertelsen et al. ... 424/489 4562.26. A 12/1985 Hirata et al... 548.184 6,749,867 B2 6/2004 Robinson et al. ... 424/489 4,619,934. A 10/1986 Sunshine et al. 514,277 6,780,882 B2 8/2004 Phillips ... ... 514,338 4,676.984 A 6, 1987 Wu et al. ..... 424,689 6,787,164 B2 9, 2004 Gelber et al. ... 424,729 4704.278 A 1/1987 Wietal. 424,688 6,797.283 B1 9/2004 Edgren et al. ... 424/472 4726.951 A 2f1988 Panoz et all 424/465 6,869,615 B2 3/2005 Chen et al. .................... 424/464 4,738,974. A 4, 1988 Brandstrom ... 514,338 6,875,872 B1 4/2005 Lindberg et al. 4,757,060 A 7, 1988 Lukacsko et al. 514,160 6,926,907 B2 8/2005 Plachetka ..................... 424,472 4,758,579 A 7, 1988 Kohl et al. ......... 514,338 7,029,701 B2 4/2006 Chen ............... ... 424/489 4,766,117 A 8, 1988 Crawford et al. ............. 514,219 7,030,162 B2 4/2006 Plachetka et al. ... 514,619 4.786,505 A 1 1/1988 Lovgren et al. ............... 424/468 7,060,694 B2 6/2006 Plachetka et al. 514,177 4,853,230 A 8/1989 Lovgren et al. 424/466 7,094,425 B2 8/2006 Scott et al. ...... ... 424/451 4,865,847. A 9, 1989 Gosswein .......... 424/439 7,332,183 B2 2/2008 Plachetka et al. ... 424/472 4.948,581 A 8/1990 Sawayanagi et al. ......... 424/497 7,399,772 B2 7/2008 Phillips ........................ 514,338 4,965,065. A 10/1990 Lukacsko et al. .. 514,162 7,411,070 B2 8/2008 Cotton et al. 5,026,560 A 6, 1991 Makino et al. 424/494 7488,497 B2 2/2009 Depui et al. .................. 424,472 5,035,899 A 7/1991 Saeki et al. ... 424/480 7,745,466 B2 6/2010 Cotton et al. 5,037,815 A 8, 1991 Lukacsko et al. .. 514,162 7,785,626 B2 8/2010 Pettersson et al. ............ 424/471 5,043,358 A 8, 1991 Lukacsko et al. .. 514,653 7,846,914 B2 12/2010 Petrus ............................. 51462 5,051.262 A 9, 1991 Panoz et al. .... 424/468 8,206,741 B2 6/2012 Plachetka et al. 5,093,132 A 3, 1992 Makino et al. 424/475 2001 OO25107 A1 9, 2001 Barberich et al. ......... 546,273.7 5,204.18 A 4, 1993 Goldman et al. .. 424/489 2002/0012676 A1 1/2002 Lundberg et al. ... 424/468 5,260.333 A 11, 1993 Lukacsko et al. ............. 514,471 2002fOO42433 A1 4/2002 Yelle et al. ...... ... 514,100 5,364,616 A 1 1/1994 Singer et al. .................... 424,52 2002fOO44962 A1 4/2002 Cherukuri et al. ... 424/426 5,373,022 A 12/1994 Fawzi et al. 514,570 2002/0045184 A1 4/2002 Chen ............... ... 435/6.16 5,409,709 A 4/1995 Ozawa et al. .. 424/464 2002fOO86029 A1 7/2002 Lundberg et al. ... 424/468 5417,980 A 5, 1995 Goldman et al. 424/464 2002/0090395 A1 7, 2002 Woolfe et al. ... ... 424/400 5,466.436 A 11/1995 Stables ....... 514, 161 2002/011 1370 A1 8/2002 Bergman et al. ... 514,338 5,514,663 A 5, 1996 Mandel .... ... 514/33 2002/0155153 A1 10/2002 Depui et al. .................. 424/452 5,601,843. A 2f1997 Gilmet ......... 424/475 2002fO16004.6 A1 10, 2002 Robinson et al. ............. 424/469 5,631,022 A 5/1997 Mandel et al. 424/456 2003, OOO8903 A1 1/2003 Barberich et al. ............ 514/100 5.643,960 A 7, 1997 Breitner et al. ............... 514/57O 2003/0040537 A1 2/2003 Plachetka et al. ............. 514,406 5,667.803 A 9/1997 Grimberg ...................... 424/464 2003.01.13375 A1 6/2003 Lundberg et al. ... 424/468 5.679.376 A 10, 1997 Stevens et al. 424/472 2003/0129235 A1 7/2003 Chen et al. ... 424/470 5686.105. A 1/1997 Kelmetal. 424/452 2003/0215527 A1 1 1/2003 Phillips ........ ... 424/747 5,690,960 A 11/1997 Bengtsson et al. 2003/0232080 A1 12/2003 Pather et al. ... 424/434 5,702,723 A 12, 1997 Griffin .......................... 424/463 2003/0232876 A1 12/2003 Pachetka .... ... 514,419 5,714,504 A 2/1998 Lindberg et al. 2004/0022846 A1 2/2004 Depui et al. .................. 424/452 5,716,648 A 2, 1998 Halskov et al. ............... 424,682 2004/0048896 A1 3/2004 Phillips ......................... 424/468 5,750,531 A 5, 1998 Lee et al. ........... 514,256 2004/O121004 A1 6/2004 Taneja . ... 424/464 5,817.338 A 10/1998 Bergstrand et al. 424/468 2004/0131676 Al 72004 Taneja . ... 424/468 5,817,340 A 10, 1998 Roche et al. ... 424/470 2004/0171646 A1 9/2004 Phillips ........ 514,340 5,840,737 A 1 1/1998 Phillips ....... 514,338 2004/0180089 A1 9, 2004 Plachetka et al. ... 424/4 5.872,145 A 2f1999 Plachetka ... 514,415 2005, 00041.71 A1 1/2005 Phillips ........ 514,340 5,877.192 A * 3/1999 Lindberget al. 514,338 2005/0042304 A1 2/2005 Phillips. ... 424/747 5,900,424 A 5, 1999 Kallstrom et al. 2005.0054682 A1 3/2005 Phillips ........ ... 514,340 5,955.451 A 9/1999 Lichtenberger et al. ........ 514,78 2005, 01476.68 A1 7/2005 Bertelsen et al. ... 424/489 6,013,281 A 1/2000 Lundberg et al. ..... 424/468 2005, 0163847 A1 7/2005 Cheng et al. ... ... 424/464 6.025.395 A 2/2000 Breitner et al. 514,570 2005/0227949 A1 10/2005 Edalatpour etal ... 514,338 6,060,499 A 5, 2000 Plachetka ... 514,415 2005/0249806 A1 11/2005 Proehl et al. .... ... 514,338 6,095.734 A 7/2000 Garst et al. .. 514,338 2005/0249811 A1 11/2005 Plachetka ..................... 424,472 6.132.768 A 10, 2000 Sachs et al. 424/458 2006/O165797 A1 7/2006 Plachetka ..................... 514,165 65277 A 10/2000 Depui et al. 424/468 2006/0177504 A1 8/2006 Sundharadas ..

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    21 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us